![conference banner](/images/conference-banner.jpeg)
Abstract
Objective: Available conventional therapies are commonly used for the treatment of breast cancer, such as surgical procedures, hormonal therapy, radiation therapy, and chemotherapy. These therapies can be either given alone or in combination with other therapies. Various side effects associated with chemotherapies, including toxicity and multidrug resistance, have limited the use of chemotherapy, thus making it less effective than the above mentioned therapies. This review focus has been summarised as the application of anticancer with phytoconstituents that could be a promising and effective treatment strategy for breast cancer treatment.
Methods: This review is designed on relevant literature that was screened on the basis of in-scope criteria in the title, abstract, and keywords of the searched articles. The available literature was searched on PubMed, ScienceDirect, MedlinePlus, and Google scholar up to May 2021. A total of 47 articles were selected out of 168 articles based on inclusion and exclusion criteria.
Results: The major limitations accompanying available conventional treatment, mainly chemotherapy, include low bioavailability at the specific site of tumor cells, the occurrence of multidrug resistance, and high doserelated side effects. The phytoconstituents possessing anticancer properties and, when used in combination with chemotherapeutic agents, impart promising and potential therapeutic value. Many in vitro and in vivo studies showed that phytoconstituents could enhance the effectiveness of chemotherapy drugs for breast cancer treatment.
Conclusion: The combination approaches of phytoconstituents with chemotherapeutic drugs provide less toxicity to normal cells, reduce side effects, and overcome multidrug resistance, thus making the combination approaches an effective strategy for the treatment of breast cancer.
Keywords: Breast cancer, phytoconstituent, chemotherapy, combination approach, toxicity, side effects, multidrug resistance.
Current Pharmaceutical Design
Title:Assessment of Combination Approaches of Phytoconstituents with Chemotherapy for the Treatment of Breast Cancer: A Systematic Review
Volume: 27 Issue: 45
Author(s): Ali Sartaj, Sanjula Baboota and Javed Ali*
Affiliation:
- Department of Pharmaceutics, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi-110062,India
Keywords: Breast cancer, phytoconstituent, chemotherapy, combination approach, toxicity, side effects, multidrug resistance.
Abstract:
Objective: Available conventional therapies are commonly used for the treatment of breast cancer, such as surgical procedures, hormonal therapy, radiation therapy, and chemotherapy. These therapies can be either given alone or in combination with other therapies. Various side effects associated with chemotherapies, including toxicity and multidrug resistance, have limited the use of chemotherapy, thus making it less effective than the above mentioned therapies. This review focus has been summarised as the application of anticancer with phytoconstituents that could be a promising and effective treatment strategy for breast cancer treatment.
Methods: This review is designed on relevant literature that was screened on the basis of in-scope criteria in the title, abstract, and keywords of the searched articles. The available literature was searched on PubMed, ScienceDirect, MedlinePlus, and Google scholar up to May 2021. A total of 47 articles were selected out of 168 articles based on inclusion and exclusion criteria.
Results: The major limitations accompanying available conventional treatment, mainly chemotherapy, include low bioavailability at the specific site of tumor cells, the occurrence of multidrug resistance, and high doserelated side effects. The phytoconstituents possessing anticancer properties and, when used in combination with chemotherapeutic agents, impart promising and potential therapeutic value. Many in vitro and in vivo studies showed that phytoconstituents could enhance the effectiveness of chemotherapy drugs for breast cancer treatment.
Conclusion: The combination approaches of phytoconstituents with chemotherapeutic drugs provide less toxicity to normal cells, reduce side effects, and overcome multidrug resistance, thus making the combination approaches an effective strategy for the treatment of breast cancer.
Export Options
About this article
Cite this article as:
Sartaj Ali , Baboota Sanjula and Ali Javed *, Assessment of Combination Approaches of Phytoconstituents with Chemotherapy for the Treatment of Breast Cancer: A Systematic Review, Current Pharmaceutical Design 2021; 27 (45) . https://dx.doi.org/10.2174/1381612827666210902155752
DOI https://dx.doi.org/10.2174/1381612827666210902155752 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
Call for Papers in Thematic Issues
Blood-based biomarkers in large-scale screening for neurodegenerative diseases
Disease biomarkers are necessary tools that can be employ in several clinical context of use (COU), ranging from the (early) diagnosis, prognosis, prediction, to monitor of disease state and/or drug efficacy. Regarding neurodegenerative diseases, in particular Alzheimer’s disease (AD), a battery of well-validated biomarkers are available, such as cerebrospinal fluid ...read more
Current Pharmaceutical challenges in the treatment and diagnosis of neurological dysfunctions
Neurological dysfunctions (MND, ALS, MS, PD, AD, HD, ALS, Autism, OCD etc..) present significant challenges in both diagnosis and treatment, often necessitating innovative approaches and therapeutic interventions. This thematic issue aims to explore the current pharmaceutical landscape surrounding neurological disorders, shedding light on the challenges faced by researchers, clinicians, and ...read more
Diabetes mellitus: advances in diagnosis and treatment driving by precision medicine
Diabetes mellitus (DM) is a chronic degenerative metabolic disease with ever increasing prevalence worldwide which is now an epidemic disease affecting 500 million people worldwide. Insufficient insulin secretion from pancreatic β cells unable to maintain blood glucose homeostasis is the main feature of this disease. Multifactorial and complex nature of ...read more
Emerging and re-emerging diseases
Faced with a possible endemic situation of COVID-19, the world has experienced two important phenomena, the emergence of new infectious diseases and/or the resurgence of previously eradicated infectious diseases. Furthermore, the geographic distribution of such diseases has also undergone changes. This context, in turn, may have a strong relationship with ...read more
![Wayfinder Image](/images/wayfinder.jpg)
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Anti-inflammatory Effects of Mesenchymal Stem Cells and their Secretomes
in Pneumonia
Current Pharmaceutical Biotechnology MicroRNAs in Cancer Therapy: From Bench to Bedside
Current Cancer Therapy Reviews The Potential Role of Pro-Inflammatory and Anti-Inflammatory Cytokines in Epilepsy Pathogenesis
Endocrine, Metabolic & Immune Disorders - Drug Targets Celecoxib in Cancer Therapy and Prevention – Review
Current Drug Targets Anesthesia and Postoperative Cognitive Dysfunction (POCD)
Central Nervous System Agents in Medicinal Chemistry Chemotherapeutic Options for Colorectal Cancer Patients with Cardiovascular Diseases.
Reviews on Recent Clinical Trials Combination Therapy of Chemotherapy or Radiotherapy and the Neurokinin-1 Receptor Antagonist Aprepitant: A New Antitumor Strategy?
Current Medicinal Chemistry Acute Cerebral Blood Flow Variations after Human Cardiac Arrest Assessed by Stable Xenon Enhanced Computed Tomography
Current Neurovascular Research Sphingosine Kinases Signalling in Carcinogenesis
Mini-Reviews in Medicinal Chemistry Apoptosis and Oxidative Stress-Related Diseases: The p66Shc Connection
Current Molecular Medicine Mitochondria and Organismal Longevity
Current Genomics Targeting the Voltage-Dependent K+ Channels Kv1.3 and Kv1.5 as Tumor Biomarkers for Cancer Detection and Prevention
Current Medicinal Chemistry Statin-induced Vascular Smooth Muscle Cell Apoptosis: A Possible Role in the Prevention of Restenosis?
Current Drug Targets - Cardiovascular & Hematological Disorders Subject index to volume 3
Current Molecular Medicine Organ Preference of Cancer Metastasis and Metastasis-Related Cell Adhesion Molecules Including Carbohydrates
Cardiovascular & Hematological Disorders-Drug Targets Role of Phytochemicals in the Prevention of Menopausal Bone Loss: Evidence from In Vitro and In Vivo, Human Interventional and Pharmacokinetic Studies
Current Medicinal Chemistry MicroRNAs: Novel Diagnostic and Prognostic Biomarkers in Atherosclerosis
Current Topics in Medicinal Chemistry Cucurbitacins and the Immune System: Update in Research on Anti- inflammatory, Antioxidant, and Immunomodulatory Mechanisms
Current Medicinal Chemistry Radiolabeled Probes Targeting Tyrosine-Kinase Receptors For Personalized Medicine
Current Pharmaceutical Design General or Local Anesthesia for TAVI? A Systematic Review of the Literature and Meta-Analysis
Current Pharmaceutical Design